Parijat Life Science

Marketing of healthcare products including eye drops and supplements.

About Parijat Life Science

Parijat Life Science is a Healthcare company. Marketing of healthcare products including eye drops and supplements. Its Indian entity Parijat Lifescience Private Limited reported revenue of β‚Ή52.2 Lakh. Parijat Life Science offers products and services including Pariflam Eye Drops and Antivita Plus Tablet. Its focus areas include Pharmaceuticals, Ophthalmic Products, Eye Care Solutions and Nutraceuticals.

Company details

Parijat Life Science was established in April 2017 with the objective of delivering affordable healthcare services through the marketing of multispeciality products. A variety of eye drops, such as Multicool for quality eye care and Dew Tears for lubrication of irritated eyes, are handled by the company, along with tablets like Antivita Plus for nutritional support. Operations are based in Nalasopara, Maharashtra, India, where efforts are directed towards making healthcare accessible via product distribution and contact facilitation. Contact details, including email and phone numbers, are provided for inquiries.

Key Metrics
  • Indian entity revenue
    ₹52.2 Lakh

    FY 2023 · +45% YoY

  • Indian entity net profit
    ₹1.9 Lakh

    FY 2023 · 4% margin

  • Indian entity EBITDA
    ₹2.8 Lakh

    FY 2023 · 5% margin

Products & Services of Parijat Life Science

Parijat Life Science offers a comprehensive portfolio of products and services, including Pariflam Eye Drops and Antivita Plus Tablet.

Pariflam Eye Drops
Ophthalmic Products

Pariflam Eye Drops are used as a topical anti-infective for treating bacterial conjunctivitis

Antivita Plus Tablet
Supplements

Antivita Plus Tablet is provided as a supplement that acts against ARMD and supports body nutrition

Board of directors of Parijat Lifescience Private Limited (Parijat Life Science)

Parijat Lifescience Private Limited is the primary company behind Parijat Life Science. The board of Parijat Lifescience Private Limited currently have 2 directors; the longest-serving is Seema Maurya, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Seema Maurya
DIN 07772630
Director07 Apr 20179 yrs 7 moParijat Lifescience Private Limited
Monu Maurya Radhey Shyam
DIN 07772639
Director07 Apr 20179 yrs 7 moParijat Lifescience Private Limited

Financials of Parijat Life Science

Figures of Parijat Lifescience Private Limited, the primary company behind Parijat Life Science, for FY 2023. Revenue was ₹52.2 Lakh (+45% year on year). Net profit was ₹1.9 Lakh (4% margin). EBITDA was ₹2.8 Lakh (5% margin). Revenue has grown at a compounded annual rate of +21% over three years and +48% over five years.

  • ₹52.2 LakhRevenue · FY 2023 · +45% YoY
  • ₹1.9 LakhNet profit · 4% margin
  • ₹2.8 LakhEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • +21%Revenue CAGR, 3 years
  • +48%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Parijat Lifescience Private Limited are on its company page.

Premium access

Detailed financial statements for Parijat Life Science

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Parijat Life Science

The primary company behind Parijat Life Science, Parijat Lifescience Private Limited, reported revenue of β‚Ή52.2 Lakh for FY 2023, up 45% year on year.

Parijat Life Science was established in April 2017 with the objective of delivering affordable healthcare services through the marketing of multispeciality products. A variety of eye drops, such as Multicool for quality eye care and Dew Tears for lubrication of irritated eyes, are handled by the company, along with tablets like Antivita Plus for nutritional support. Operations are based in Nalasopara, Maharashtra, India, where efforts are directed towards making healthcare accessible via product distribution and contact facilitation. Contact details, including email and phone numbers, are provided for inquiries.

Parijat Life Science offers Pariflam Eye Drops and Antivita Plus Tablet.

Parijat Life Science operates through Parijat Lifescience Private Limited.

The legal entities of Parijat Life Science currently have 2 directors, including Seema Maurya, Monu Maurya Radhey Shyam.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available